CAM
GILD icon

Covenant Asset Management’s Gilead Sciences GILD Stock Holding History

Covenant Asset Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-5,400
Closed -$20K – 143
2018
Q1 		$20K Buy
+5,400
New +$429K 0.01% 144

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Covenant Asset Management's GILD Position: Q1 2019 in Review

Covenant Asset Management sold out of Gilead Sciences (GILD) in Q1 2019, closing a stake of 3,325 shares — an estimated $257K sold.

Covenant Asset Management first reported a position in GILD in Q4 2016 and held it in 9 quarters. The position peaked at $978K in Q4 2016. 1,491 funds tracked by Wall St. Rank hold GILD as of Q1 2019.

  • Covenant Asset Management reported no remaining Gilead Sciences position as of Q1 2019 after selling out during the quarter.
  • Covenant Asset Management sold 3,325 Gilead Sciences shares in Q1 2019, an estimated $257K.
  • Covenant Asset Management first reported a position in Gilead Sciences in Q4 2016 and held it in 9 quarters.
  • Covenant Asset Management's Gilead Sciences position peaked at $978K in Q4 2016.
  • 1,491 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2019.

Based on Covenant Asset Management's 13F filing for Q1 2019, filed 26 Apr 2019.